MicroRNAs as molecular targets of quercetin and its derivatives underlying their biological effects: A preclinical strategy

References

• Ahmad, A., S. H. Sarkar, B. Bitar, S. Ali, A. Aboukameel, S. Sethi, Y. Li, B. Bao, D. Kong, S. Banerjee, S. B. Padhye, and F. H. Sarkar. 2012. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells. Molecular Cancer Therapeutics 11:2193–201. doi:10.1158/1535-7163.MCT-12-0232-T.
   PubMed Web of Science ®Google Scholar
• Alvarez-Díaz, S., N. Valle, G. Ferrer-Mayorga, L. Lombardía, M. Herrera, O. Domínguez, M. F. Segura, F. Bonilla, E. Hernando, and A. Muñoz. 2012. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Human Molecular Genetics 21:2157–65. doi:10.1093/hmg/dds031.
   PubMed Web of Science ®Google Scholar
• Angst, E., J. L. Park, A. Moro, Q. Y. Lu, X. Lu, G. Li, J. King, M. Chen, H. A. Reber, V. L. Go, G. Eibl, and O. J. Hines. 2013. The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas 42:223–29. doi:10.1097/MPA.0b013e318264ccae.
   PubMed Web of Science ®Google Scholar
• Appari, M., K. R. Babu, A. Kaczorowski, W. Gross, and I. Herr. 2014. Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. Int J Oncol 45:1391–400. doi:10.3892/ijo.2014.2539.
   PubMed Web of Science ®Google Scholar
• Banerjee, N., S. Talcott, S. Safe, and S. U. Mertens-Talcott. 2012. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Research and Treatment 136:21–34. doi:10.1007/s10549-012-2224-0.
   PubMed Web of Science ®Google Scholar
• Bartel, D. P. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281–97. doi:10.1016/S0092-8674(04)00045-5.
   PubMed Web of Science ®Google Scholar
• Bartel, D. P. 2009. MicroRNA target recognition and regulatory functions. Cell 136:215–33. doi:10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Ben-Neriah, Y., and M. Karin. 2011. Inflammation meets cancer, with NF-[kappa]B as the matchmaker. Nature Immunology 12:715–23. doi:10.1038/ni.2060.
   PubMed Web of Science ®Google Scholar
• Bhaumik, D., G. K. Scott, S. Schokrpur, C. K. Patil, J. Campisi, and C. C. Benz. 2008. Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27:5643–47. doi:10.1038/onc.2008.171.
   PubMed Web of Science ®Google Scholar
• Biesaga, M., and K. Pyrzynska. 2009. Analytical procedures for determination of quercetin and its glycosides in plant material. Critical Reviews in Analytical Chemistry 39:95–107. doi:10.1080/10408340902820718.
   Web of Science ®Google Scholar
• Boesch-Saadatmandi, C., A. Loboda, A. E. Wagner, A. Stachurska, A. Jozkowicz, J. Dulak, F. Doring, S. Wolffram, and G. Rimbach. 2011. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. Journal of Nutrition Biochemestry 22:293–99. doi:10.1016/j.jnutbio.2010.02.008.
   PubMed Web of Science ®Google Scholar
• Boesch-Saadatmandi, C., A. E. Wagner, S. Wolffram, and G. Rimbach. 2012. Effect of quercetin on inflammatory gene expression in mice liver in vivo – role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacological Research 65:523–30. doi:10.1016/j.phrs.2012.02.007.
   PubMed Web of Science ®Google Scholar
• Bonfrate, L., D. F. Altomare, M. Di Lena, E. Travaglio, M. T. Rotelli, A. De Luca, and P. Portincasa. 2013. MicroRNA in colorectal cancer: New perspectives for diagnosis, prognosis and treatment. Journal of gastrointestinal and liver diseases: JGLD 22:311–20.
   PubMed Web of Science ®Google Scholar
• Boots, A. W., G. R. M. M. Haenen, and A. Bast. 2008. Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology 585:325–37. doi:10.1016/j.ejphar.2008.03.008.
   PubMed Web of Science ®Google Scholar
• Burak, C., V. Brüll, P. Langguth, B. F. Zimmermann, B. Stoffel-Wagner, U. Sausen, P. Stehle, S. Wolffram, and S. Egert. 2017. Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans. European journal of nutrition 56:343–53. doi:10.1007/s00394-015-1084-x.
   PubMed Web of Science ®Google Scholar
• Calin, G. A., C. Sevignani, C. D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, and M. Negrini. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National academy of Sciences of the United States of America 101:2999–3004. doi:10.1073/pnas.0307323101.
   PubMed Web of Science ®Google Scholar
• Cermak, R., S. Landgraf, and S. Wolffram. 2003. The Bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. The Journal of Nutrition 133:2802–2807. doi:10.1093/jn/133.9.2802.
   PubMed Web of Science ®Google Scholar
• Cerutti, P. A. 1985. Prooxidant states and tumor promotion. Science 227:375. doi:10.1126/science.2981433.
   PubMed Web of Science ®Google Scholar
• Chakrabarti, M., M. Khandkar, N. L. Banik, and S. K. Ray. 2012. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Research 1454:1–13. doi:10.1016/j.brainres.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Chang, T.-C., E. A. Wentzel, O. A. Kent, K. Ramachandran, M. Mullendore, K. H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C. J. Lowenstein, D. E. Arking, M. A. Beer, A. Maitra, and J. T. Mendell. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 26:745–52. doi:10.1016/j.molcel.2007.05.010.
   PubMed Web of Science ®Google Scholar
• Chang, T.-C., D. Yu, Y.-S. Lee, E. A. Wentzel, D. E. Arking, K. M. West, C. V. Dang, A. Thomas-Tikhonenko, and J. T. Mendell. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature genetics 40:43–50. doi:10.1038/ng.2007.30.
   PubMed Web of Science ®Google Scholar
• Chen, X., E. Mukwaya, M.-S. Wong, and Y. Zhang. 2014. A systematic review on biological activities of prenylated flavonoids. Pharmaceutical Biology 52:655–60. doi:10.3109/13880209.2013.853809.
   PubMed Web of Science ®Google Scholar
• Chen, Y., M. S. Zaman, G. Deng, S. Majid, S. Saini, J. Liu, Y. Tanaka, and R. Dahiya. 2011. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prevention Research 4:76. doi:10.1158/1940-6207.CAPR-10-0167.
   PubMed Web of Science ®Google Scholar
• Chiyomaru, T., S. Yamamura, S. Fukuhara, H. Hidaka, S. Majid, S. Saini, S. Arora, G. Deng, V. Shahryari, I. Chang, Y. Tanaka, Z. L. Tabatabai, H. Enokida, N. Seki, M. Nakagawa, and R. Dahiya. 2013. Genistein Up-regulates tumor suppressor MicroRNA-574-3p in prostate cancer. PLOS ONE 8:e58929. doi:10.1371/journal.pone.0058929.
   PubMed Web of Science ®Google Scholar
• Chiyomaru, T., S. Yamamura, S. Fukuhara, H. Yoshino, T. Kinoshita, S. Majid, S. Saini, I. Chang, Y. Tanaka, H. Enokida, N. Seki, M. Nakagawa, and R. Dahiya. 2013. Genistein inhibits prostate cancer cell growth by targeting miR-34a and Oncogenic HOTAIR. PLOS ONE 8:e70372. doi:10.1371/journal.pone.0070372.
   PubMed Web of Science ®Google Scholar
• Chiyomaru, T., S. Yamamura, M. S. Zaman, S. Majid, G. Deng, V. Shahryari, S. Saini, H. Hirata, K. Ueno, I. Chang, Y. Tanaka, Z. L. Tabatabai, H. Enokida, M. Nakagawa, and R. Dahiya. 2012. Genistein suppresses prostate cancer growth through inhibition of oncogenic MicroRNA-151. PLOS ONE 7:e43812. doi:10.1371/journal.pone.0043812.
   PubMed Web of Science ®Google Scholar
• Chun, O. K., S. J. Chung, and W. O. Song. 2007. Estimated dietary flavonoid intake and major food sources of U.S. Adults. The Journal of Nutrition 137:1244–52. doi:10.1093/jn/137.5.1244.
   PubMed Web of Science ®Google Scholar
• Crone, S. G., A. Jacobsen, B. Federspiel, L. Bardram, A. Krogh, A. H. Lund, and L. Friis-Hansen. 2012. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 11:71. doi:10.1186/1476-4598-11-71.
   PubMed Web of Science ®Google Scholar
• Dajas, F. 2012. Life or death: Neuroprotective and anticancer effects of quercetin. Journal of Ethnopharmacology 143:383–96. doi:10.1016/j.jep.2012.07.005.
   PubMed Web of Science ®Google Scholar
• Dangles, O., C. Dufour, and G. Fargeix. 2000. Inhibition of lipid peroxidation by quercetin and quercetin derivatives: antioxidant and prooxidant effects. Journal of the Chemical Society, Perkin Transactions 2 6:1215–22. doi:10.1039/a910183g.
   Google Scholar
• Davidson, L. A., N. Wang, M. S. Shah, J. R. Lupton, I. Ivanov, and R. S. Chapkin. 2009. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30:2077–84. doi:10.1093/carcin/bgp245.
   PubMed Web of Science ®Google Scholar
• Davidson, L. A., N. Wang, M. S. Shah, J. R. Lupton, I. Ivanov, and R. S. Chapkin. 2009. n -3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30:2077–84. doi:10.1093/carcin/bgp245.
   PubMed Web of Science ®Google Scholar
• Davis, C. D., and S. A. Ross. 2008. Evidence for dietary regulation of microRNA expression in cancer cells. Nutrition Reviews 66:477–82. doi:10.1111/j.1753-4887.2008.00080.x.
   PubMed Web of Science ®Google Scholar
• Day, A. J., F. Mellon, D. Barron, G. Sarrazin, M. R. A. Morgan, and G. Williamson. 2001. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin. Free Radical Research 35:941–52. doi:10.1080/10715760100301441.
   PubMed Web of Science ®Google Scholar
• Del Follo-Martinez, A., N.Li. Banerjee, S. X. Safe, and S. Mertens-Talcott. 2013. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutrition and Cancer 65:494–504. doi:10.1080/01635581.2012.725194.
   PubMed Web of Science ®Google Scholar
• Delmas, D., C. Rébé, O. Micheau, A. Athias, P. Gambert, S. Grazide, G. Laurent, N. Latruffe, and E. Solary. 2004. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23:8979. doi:10.1038/sj.onc.1208086.
   PubMed Web of Science ®Google Scholar
• Derry, M. M., K. Raina, V. Balaiya, A. K. Jain, S. Shrotriya, K. M. Huber, N. J. Serkova, R. Agarwal, and C. Agarwal. 2013. Grape seed extract efficacy against azoxymethane-induced colon tumorigenesis in A/J mice: interlinking miRNA with cytokine signaling and inflammation. Cancer prevention research (Philadelphia, Pa.) 6:625–33. doi:10.1158/1940-6207.CAPR-13-0053.
   PubMed Web of Science ®Google Scholar
• Dhar, S., C. Hicks, and A. S. Levenson. 2011. Resveratrol and prostate cancer: Promising role for microRNAs. Molecular Nutrition & Food Research 55:1219–29. doi:10.1002/mnfr.201100141.
   PubMed Web of Science ®Google Scholar
• Disis, M. L. 2010. Immune regulation of cancer. Journal of Clinical Oncology 28:4531–38. doi:10.1200/JCO.2009.27.2146.
   PubMed Web of Science ®Google Scholar
• Donovan, J. L., C. Manach, R. M. Faulks, and P. A. Kroon. 2007. Absorption and metabolism of dietary plant secondary metabolites. In: Plant secondary metabolites: Occurrence, Structure and Role in the Human Diet, ed. A. Crozier, M. N. Clifford and H. Ashihara, pp. 303–351. Blackwell Publishing Ltd, Oxford, UK. doi:10.1002/9780470988558.ch8.
   Google Scholar
• Ferdin, J., T. Kunej, and G. A. Calin. 2010. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technology in Cancer Research & Treatment 9:123–38. doi:10.1177/153303461000900202.
   PubMed Web of Science ®Google Scholar
• Fresco, P., F. Borges, C. Diniz, and M. P. M. Marques. 2006. New insights on the anticancer properties of dietary polyphenols. Medicinal Research Reviews 26:747–66. doi:10.1002/med.20060.
   PubMed Web of Science ®Google Scholar
• Gaedicke, S., X. Zhang, C. Schmelzer, Y. Lou, F. Doering, J. Frank, and G. Rimbach. 2008. Vitamin E dependent microRNA regulation in rat liver. FEBS Letters 582:3542–46. doi:10.1016/j.febslet.2008.09.032.
   PubMed Web of Science ®Google Scholar
• Garelnabi, M., and H. Mahini. 2014. Modulation of microRNA 21, 125 b and 451 expression by quercetin intake and exercise in mice fed atherogenic diet. Biomedicine & Preventive Nutrition 4:359–63. doi:10.1016/j.bionut.2014.04.005.
   Google Scholar
• Gennarino, V. A., G. D'Angelo, G. Dharmalingam, S. Fernandez, G. Russolillo, R. Sanges, M. Mutarelli, V. Belcastro, A. Ballabio, P. Verde, M. Sardiello, and S. Banfi. 2012. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Research 22:1163–72. doi:10.1101/gr.130435.111.
   PubMed Web of Science ®Google Scholar
• Guo, J., W. Li, H. Shi, X. Xie, L. Li, H. Tang, M. Wu, Y. Kong, L. Yang, J. Gao, P. Liu, W. Wei, and X. Xie. 2013. Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a. Molucular and Cellular Biochemestry 382:103–11. doi:10.1007/s11010-013-1723-6.
   PubMed Web of Science ®Google Scholar
• Han, S.-S., S.-T. Chung, D. A. Robertson, D. Ranjan, and S. Bondada. 1999. Curcumin causes the growth arrest and apoptosis of B Cell Lymphoma by Downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53. Clinical Immunology 93:152–61. doi:10.1006/clim.1999.4769.
   PubMed Web of Science ®Google Scholar
• Han, Z., Q. Yang, B. Liu, J. Wu, Y. Li, C. Yang, and Y. Jiang. 2012. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol. Carcinogenesis 33:131–39. doi:10.1093/carcin/bgr226.
   PubMed Web of Science ®Google Scholar
• Harborne, J. B., and C. A. Williams. 2001. Anthocyanins and other flavonoids. Natural Product Reports 18:310–33. doi:10.1039/b006257j.
   PubMed Web of Science ®Google Scholar
• Heber, D. 2008. Multitargeted therapy of cancer by ellagitannins. Cancer letters 269:262–68. doi:10.1016/j.canlet.2008.03.043.
   PubMed Web of Science ®Google Scholar
• Hu, S., T. S. Dong, S. R. Dalal, F. Wu, M. Bissonnette, J. H. Kwon, and E. B. Chang. 2011. The microbe-derived short chain fatty acid butyrate targets miRNA-Dependent p21 Gene Expression in human colon cancer. PLOS ONE 6:e16221. doi:10.1371/journal.pone.0016221.
   PubMed Web of Science ®Google Scholar
• Hu, S., L. Liu, E. Chang, J.-Y. Wang, and J.-P. Raufman. 2015. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Molecular cancer 14:180. doi:10.1186/s12943-015-0450-x.
   Google Scholar
• Humphreys, K. J., L. Cobiac, R. K. Le Leu, M. B. Van der Hoek, and M. Z. Michael. 2013. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Molecular Carcinogenesis 52:459–74. doi:10.1002/mc.21879.
   PubMed Web of Science ®Google Scholar
• Humphreys, K. J., M. A. Conlon, G. P. Young, D. L. Topping, Y. Hu, J. M. Winter, A. R. Bird, L. Cobiac, N. A. Kennedy, M. Z. Michael, and R. K. Le Leu. 2014. Dietary manipulation of oncogenic microRNA expression in human rectal mucosa. Cancer Prevention Research 7:786–95. doi:10.1158/1940-6207.CAPR-14-0053.
   PubMed Web of Science ®Google Scholar
• Inui, S., T. Hosoya, Y. Shimamura, S. Masuda, T. Ogawa, H. Kobayashi, K. Shirafuji, R. T. Moli, I. Kozone, K. Shin-ya, and S. Kumazawa. 2012. Solophenols B–D and solomonin: New prenylated polyphenols isolated from propolis collected from the solomon islands and their antibacterial activity. Journal of Agricultural and Food Chemistry 60:11765–70. doi:10.1021/jf303516w.
   PubMed Web of Science ®Google Scholar
• Izzotti, A., C. Cartiglia, V. E. Steele, and S. De Flora. 2012. MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutation Research/Reviews in Mutation Research 751:287–303. doi:10.1016/j.mrrev.2012.05.004.
   PubMed Web of Science ®Google Scholar
• Javeri, A., M. Ghaffarpour, M. F. Taha, and M. Houshmand. 2013. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Medical Oncology 30:413. doi:10.1007/s12032-012-0413-7.
   PubMed Web of Science ®Google Scholar
• Ji, Q., X. Hao, M. Zhang, W. Tang, M. Yang, L. Li, D. Xiang, J. T. DeSano, G. T. Bommer, D. Fan, E. R. Fearon, T. S. Lawrence, and L. Xu. 2009. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLOS ONE 4:e6816. doi:10.1371/journal.pone.0006816.
   PubMed Web of Science ®Google Scholar
• Ji, X., Z. Wang, A. Geamanu, A. Goja, F. H. Sarkar, and S. V. Gupta. 2012. Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. International Journal of Cancer 131:2668–77. doi:10.1002/ijc.27549.
   PubMed Web of Science ®Google Scholar
• Johnson, S. M., P. Gulhati, I. Arrieta, X. Wang, T. Uchida, T. Gao, and B. M. Evers. 2009. Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Research 29:3185–90.
   PubMed Web of Science ®Google Scholar
• Joven, J., V. Micol, A. Segura-Carretero, C. Alonso-Villaverde, and J. A. Menendez. 2014. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Critical Review in Food Science and Nutrition 54:985–1001. doi:10.1080/10408398.2011.621772.
   PubMed Web of Science ®Google Scholar
• Jurenka, J. S. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative medicine review: a journal of clinical therapeutic 14:141–53.
   PubMed Web of Science ®Google Scholar
• Kampa, M., A.-P. Nifli, G. Notas, and E. Castanas. 2007. Polyphenols and cancer cell growth. In: Reviews of physiology, biochemistry and pharmacology, ed. S. G. Amara, E. Bamberg, B. Fleischmann, T. Gudermann, S. C. Hebert, R. Jahn, W. J. Lederer, R. Lill, A. Miyajima, S. Offermanns, and R. Zechner pp. 79–113. Springer Berlin Heidelberg, Berlin, Heidelberg.
   Google Scholar
• Kang, J., E. Kim, W. Kim, K. M. Seong, H. Youn, J. W. Kim, J. Kim, and B. Youn. 2013. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines. Journal of Biological Chemistry 288:27343–57. doi:10.1074/jbc.M113.490482.
   PubMed Web of Science ®Google Scholar
• Kawai, Y., T. Nishikawa, Y. Shiba, S. Saito, K. Murota, N. Shibata, M. Kobayashi, M. Kanayama, K. Uchida, and J. Terao. 2008. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. The Journal of biological chemistry 283:9424–34. doi:10.1074/jbc.M706571200.
   PubMed Web of Science ®Google Scholar
• Kawanishi, S., S. Oikawa, and M. Murata. 2005. Evaluation for safety of antioxidant chemopreventive agents. Antioxidants & Redox Signaling 7:1728–39. doi:10.1089/ars.2005.7.1728.
   PubMed Web of Science ®Google Scholar
• Khan, F., K. Niaz, F. Maqbool, F. Ismail Hassan, M. Abdollahi, K. C. Nagulapalli Venkata, S. M. Nabavi, and A. Bishayee. 2016. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 8:529. doi:10.3390/nu8090529.
   PubMed Web of Science ®Google Scholar
• Kim, D.-H., E.-A. Jung, I.-S. Sohng, J.-A. Han, T.-H. Kim, and M. J. Han. 1998. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Archives of Pharmacal Research 21:17–23. doi:10.1007/BF03216747.
   PubMed Web of Science ®Google Scholar
• Konrad, M., and D. C. Nieman. 2015. Evaluation of quercetin as a countermeasure to exercise-induced physiological stress. Boca Raton, (FL): CRC Press/Taylor & Francis.
   Google Scholar
• Krichevsky, A. M., and G. Gabriely. 2009. miR-21: a small multi-faceted RNA. Journal of Cellular and Molecular Medicine 13:39–53. doi:10.1111/j.1582-4934.2008.00556.x.
   PubMed Web of Science ®Google Scholar
• Kronski, E., M. E. Fiori, O. Barbieri, S. Astigiano, V. Mirisola, P. H. Killian, A. Bruno, A. Pagani, F. Rovera, U. Pfeffer, C. P. Sommerhoff, D. M. Noonan, A. G. Nerlich, L. Fontana, and B. E. Bachmeier. 2014. miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and −2. Molecular Oncology 8:581–95. doi:10.1016/j.molonc.2014.01.005.
   PubMed Web of Science ®Google Scholar
• Kumar, V. B., T.-C. Yuan, J.-W. Liou, C.-J. Yang, P.-J. Sung, and C.-F. Weng. 2011. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 707:42–52. doi:10.1016/j.mrfmmm.2010.12.009.
   PubMed Web of Science ®Google Scholar
• Kumazaki, M., S. Noguchi, Y. Yasui, J. Iwasaki, H. Shinohara, N. Yamada, and Y. Akao. 2013. Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. The Journal of Nutritional Biochemistry 24:1849–58. doi:10.1016/j.jnutbio.2013.04.006.
   PubMed Web of Science ®Google Scholar
• Kumazaki, M., H. Shinohara, K. Taniguchi, H. Ueda, M. Nishi, A. Ryo, and Y. Akao. 2015. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative. Oncotarget 6:25828–42. doi:10.18632/oncotarget.4558.
   PubMedGoogle Scholar
• Lam, T. K., S. Shao, Y. Zhao, F. Marincola, A. Pesatori, P. A. Bertazzi, N. E. Caporaso, E. Wang, and M. T. Landi. 2012. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol Biomarkers Prev 21:2176–84. doi:10.1158/1055-9965.EPI-12-0745.
   PubMed Web of Science ®Google Scholar
• Lambert, J. D., S. Sang, and C. S. Yang. 2007. Possible controversy over dietary polyphenols: benefits vs risks. Chemical research in toxicology 20:583–85. doi:10.1021/tx7000515.
   PubMed Web of Science ®Google Scholar
• Larriba, M. J., J. M. González-Sancho, A. Barbáchano, N. Niell, G. Ferrer-Mayorga, and A. Muñoz. 2013. Vitamin D is a multilevel repressor of Wnt/b-Catenin signaling in cancer cells. Cancers 5:1242–60. doi:10.3390/cancers5041242.
   PubMedGoogle Scholar
• Lautraite, S., A. C. Musonda, J. Doehmer, G. O. Edwards, and J. K. Chipman. 2002. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1. Mutagenesis 17:45–53. doi:10.1093/mutage/17.1.45.
   PubMed Web of Science ®Google Scholar
• Lee, K. W., and H. J. Lee. 2006. The roles of polyphenols in cancer chemoprevention. BioFactors 26:105–21. doi:10.1002/biof.5520260202.
   PubMed Web of Science ®Google Scholar
• Lewandowska, H., M. Kalinowska, W. Lewandowski, T. M. Stępkowski, and K. Brzóska. 2016. The role of natural polyphenols in cell signaling and cytoprotection against cancer development. The Journal of Nutritional Biochemistry 32:1–19. doi:10.1016/j.jnutbio.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell 120:15–20. doi:10.1016/j.cell.2004.12.035.
   PubMed Web of Science ®Google Scholar
• Li, W., M. Liu, Y. F. Xu, Y. Feng, J. P. Che, G. C. Wang, and J. H. Zheng. 2014. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Oncology Report 31:117–24. doi:10.3892/or.2013.2811.
   PubMed Web of Science ®Google Scholar
• Li, Y., T. G. VandenBoom, Kong, D. 2nd, Z. Wang, S. Ali, P. A. Philip, and F. H. Sarkar. 2009. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69:6704–12. doi:10.1158/0008-5472.CAN-09-1298.
   PubMed Web of Science ®Google Scholar
• Li, Y., J. Yao, C. Han, J. Yang, M. Chaudhry, S. Wang, H. Liu, and Y. Yin. 2016. Quercetin, inflammation and immunity. Nutrients 8:167. doi:10.3390/nu8030167.
   PubMed Web of Science ®Google Scholar
• Lim, L. P., N. C. Lau, P. Garrett-Engele, A. Grimson, J. M. Schelter, J. Castle, D. P. Bartel, P. S. Linsley, and J. M. Johnson. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769–73. doi:10.1038/nature03315.
   PubMed Web of Science ®Google Scholar
• Lin, Y.-T., S.-L. Hsiu, Y.-C. Hou, H.-Y. Chen, and P.-D. L. Chao. 2003. Degradation of flavonoid aglycones by rabbit, rat and human fecal flora. Biological and Pharmaceutical Bulletin 26:747–51. doi:10.1248/bpb.26.747.
   PubMed Web of Science ®Google Scholar
• Linsalata, M., A. Orlando, C. Messa, M. G. Refolo, and F. Russo. 2010. Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis. Anticancer Research 30:3501–3507.
   PubMed Web of Science ®Google Scholar
• Liu, P., H. Liang, Q. Xia, P. Li, H. Kong, P. Lei, S. Wang, and Z. Tu. 2013. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clinical and Translational Oncology 15:741–46. doi:10.1007/s12094-012-0999-4.
   PubMed Web of Science ®Google Scholar
• Liu, R. H. 2004. Potential synergy of phytochemicals in cancer prevention: Mechanism of action. The Journal of Nutrition 134:3479S–85S. doi:10.1093/jn/134.12.3479S.
   PubMed Web of Science ®Google Scholar
• Lodi, F., R. Jiménez, C. Menendez, P. W. Needs, J. Duarte, and F. Perez-Vizcaino. 2008. Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. Planta medica 74:741–46. doi:10.1055/s-2008-1074525.
   PubMed Web of Science ®Google Scholar
• Lou, G., Y. Liu, S. Wu, J. Xue, F. Yang, H. Fu, M. Zheng, and Z. Chen. 2015. The p53/miR-34a/SIRT1 positive feedback loop in quercetin-induced apoptosis. Cell Physiol Biochem 35:2192–202. doi:10.1159/000374024.
   PubMed Web of Science ®Google Scholar
• Lynn, F. C. 2009. Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends in Endocrinology & Metabolism 20:452–59. doi:10.1016/j.tem.2009.05.007.
   PubMed Web of Science ®Google Scholar
• Ma, J., L. Cheng, H. Liu, J. Zhang, Y. Shi, F. Zeng, L. Miele, F. H Sarkar, J. Xia, and Z. Wang. 2013. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Current Drug Targets 14:1150–56. doi:10.2174/13894501113149990187.
   PubMed Web of Science ®Google Scholar
• MacKenzie, T. N., N. Mujumdar, S. Banerjee, V. Sangwan, A. Sarver, S. Vickers, S. Subramanian, and A. K. Saluja. 2013. Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation. Molecular Cancer Ther 12:1266–75. doi:10.1158/1535-7163.MCT-12-1231.
   PubMed Web of Science ®Google Scholar
• Manach, C., A. Mazur, and A. Scalbert. 2005. Polyphenols and prevention of cardiovascular diseases. Current Opinion in Lipidology 16:77–84. doi:10.1097/00041433-200502000-00013.
   PubMed Web of Science ®Google Scholar
• Milenkovic, D., C. Deval, E. Gouranton, J. F. Landrier, A. Scalbert, C. Morand, and A. Mazur. 2012. Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLOS ONE 7:e29837. doi:10.1371/journal.pone.0029837.
   PubMed Web of Science ®Google Scholar
• Miranda, K. C., T. Huynh, Y. Tay, Y.-S. Ang, W.-L. Tam, A. M. Thomson, B. Lim, and I. Rigoutsos. 2006. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126:1203–17. doi:10.1016/j.cell.2006.07.031.
   PubMed Web of Science ®Google Scholar
• Muhammad, S., K. Kaur, R. Huang, Q. Zhang, P. Kaur, H. O. Yazdani, M. U. Bilal, J. Zheng, L. Zheng, and X.-S. Wang. 2014. MicroRNAs in colorectal cancer: Role in metastasis and clinical perspectives. World Journal of Gastroenterology: WJG 20:17011–19. doi:10.3748/wjg.v20.i45.17011.
   PubMed Web of Science ®Google Scholar
• Muller, P. A. J., K. H. Vousden, and J. C. Norman. 2011. p53 and its mutants in tumor cell migration and invasion. The Journal of Cell Biology 192:209. doi:10.1083/jcb.201009059.
   PubMed Web of Science ®Google Scholar
• Murakami, A., H. Ashida, and J. Terao. 2008. Multitargeted cancer prevention by quercetin. Cancer letters 269:315–25. doi:10.1016/j.canlet.2008.03.046.
   PubMed Web of Science ®Google Scholar
• Murota, K., N. Matsuda, Y. Kashino, Y. Fujikura, T. Nakamura, Y. Kato, R. Shimizu, S. Okuyama, H. Tanaka, T. Koda, K. Sekido, and J. Terao. 2010. α-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans. Archives of Biochemistry and Biophysics 501:91–97. doi:10.1016/j.abb.2010.06.036.
   PubMed Web of Science ®Google Scholar
• Mutoh, M., M. Takahashi, K. Fukuda, H. Komatsu, T. Enya, Y. Matsushima-Hibiya, H. Mutoh, T. Sugimura, and K. Wakabayashi. 2000. Suppression by Flavonoids of Cyclooxygenase-2 Promoter-dependent transcriptional activity in colon cancer cells: Structure-activity relationship. Japanese Journal of Cancer Research 91:686–91. doi:10.1111/j.1349-7006.2000.tb01000.x.
   PubMedGoogle Scholar
• Németh, K., G. W. Plumb, J.-G. Berrin, N. Juge, R. Jacob, H. Y. Naim, G. Williamson, D. M. Swallow, and P. A. Kroon. 2003. Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. European journal of nutrition 42:29–42. doi:10.1007/s00394-003-0397-3.
   PubMed Web of Science ®Google Scholar
• Nakagawa, Y., M. Iinuma, T. Naoe, Y. Nozawa, and Y. Akao. 2007. Characterized mechanism of α-mangostin-induced cell death: Caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorganic & Medicinal Chemistry 15:5620–28. doi:10.1016/j.bmc.2007.04.071.
   PubMed Web of Science ®Google Scholar
• Noratto, G. D., Y. Kim, S. T. Talcott, and S. U. Mertens-Talcott. 2011. Flavonol-rich fractions of yaupon holly leaves (Ilex vomitoria, Aquifoliaceae) induce microRNA-146a and have anti-inflammatory and chemopreventive effects in intestinal myofribroblast CCD-18Co cells. Fitoterapia 82:557–69. doi:10.1016/j.fitote.2011.01.013.
   PubMed Web of Science ®Google Scholar
• Nwaeburu, C. C., A. Abukiwan, Z. Zhao, and I. Herr. 2017. Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Mol Cancer 16:23. doi:10.1186/s12943-017-0589-8.
   PubMed Web of Science ®Google Scholar
• Nwaeburu, C. C., N. Bauer, Z. Zhao, A. Abukiwan, J. Gladkich, A. Benner, and I. Herr. 2016. Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Oncotarget 7:58367–80. doi:10.18632/oncotarget.11122.
   PubMedGoogle Scholar
• O'Leary, K. A., A. J. Day, P. W. Needs, W. S. Sly, N. M. O'Brien, and G. Williamson. 2001. Flavonoid glucuronides are substrates for human liver β-glucuronidase. FEBS Letters 503:103–106. doi:10.1016/S0014-5793(01)02684-9.
   PubMed Web of Science ®Google Scholar
• Padi, S. K. R., Q. Zhang, Y. M. Rustum, C. Morrison, and B. Guo. 2013. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 145:437–46. doi:10.1053/j.gastro.2013.04.012.
   PubMed Web of Science ®Google Scholar
• Pan, J. H., B. Abernathy, Y. J. Kim, J. H. Lee, J. H. Kim, E. C. Shin, and J. K. Kim. 2017. Cruciferous vegetables and colorectal cancer prevention through microRNA regulation: A review. Critical Reviews in Food Science and Nutrition. doi:10.1080/10408398.2017.1300134.
   PubMed Web of Science ®Google Scholar
• Parasramka, M. A., S. Ali, S. Banerjee, T. Deryavoush, F. H. Sarkar, and S. Gupta. 2013. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. Molecular Nutrition & Food Research 57:235–48. doi:10.1002/mnfr.201200297.
   PubMed Web of Science ®Google Scholar
• Parasramka, M. A., W. M. Dashwood, R. Wang, A. Abdelli, G. S. Bailey, D. E. Williams, E. Ho, and R. H. Dashwood. 2012. MicroRNA profiling of carcinogen-induced rat colon tumors and the influence of dietary spinach. Molecular Nutrition & Food Research 56:1259–69. doi:10.1002/mnfr.201200117.
   PubMed Web of Science ®Google Scholar
• Patil, C. S., V. P. Singh, P. S. V. Satyanarayan, N. K. Jain, A. Singh, and S. K. Kulkarni. 2003. Protective effect of flavonoids against aging- and Lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 69:59–67. doi:10.1159/000072357.
   PubMed Web of Science ®Google Scholar
• Petersen, B., S. Egert, A. Bosy-Westphal, M. J. Müller, S. Wolffram, E. M. Hubbermann, G. Rimbach, and K. Schwarz. 2016. Bioavailability of quercetin in humans and the influence of food matrix comparing quercetin capsules and different apple sources. Food Research International 88:159–65. doi:10.1016/j.foodres.2016.02.013.
   PubMed Web of Science ®Google Scholar
• Pillai, R. S., S. N. Bhattacharyya, and W. Filipowicz. 2007. Repression of protein synthesis by miRNAs: how many mechanisms? Trends in Cell Biology 17:118–26. doi:10.1016/j.tcb.2006.12.007.
   PubMed Web of Science ®Google Scholar
• Pratheeshkumar, P., Y.-O. Son, S. P. Divya, L. Wang, L. Turcios, R. V. Roy, J. A. Hitron, D. Kim, J. Dai, P. Asha, Z. Zhang, and X. Shi. 2017. Quercetin inhibits Cr(VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget 8:52118–31. doi:10.18632/oncotarget.10130.
   PubMedGoogle Scholar
• Priego, S., F. Feddi, P. Ferrer, S. Mena, M. Benlloch, A. Ortega, J. Carretero, E. Obrador, M. Asensi, and J. M. Estrela. 2008. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Molecular Cancer Therapeutics 7:3330. doi:10.1158/1535-7163.MCT-08-0363.
   PubMed Web of Science ®Google Scholar
• Rice-Evans, C., N. Miller, and G. Paganga. 1997. Antioxidant properties of phenolic compounds. Trends in Plant Science 2:152–59. doi:10.1016/S1360-1385(97)01018-2.
   Web of Science ®Google Scholar
• Russo, G. L., V. Vastolo, M. Ciccarelli, L. Albano, P. E. Macchia, and P. Ungaro. 2017. Dietary polyphenols and chromatin remodeling. Crit Rev Food Sci Nutr 57:2589–99. doi:10.1080/10408398.2015.1062353.
   PubMed Web of Science ®Google Scholar
• Saplacan, R. M. M., P. A. Mircea, L. Balacescu, and O. Balacescu. 2015. MicroRNAs as non-invasive screening biomarkers of colorectal cancer. Clujul Medical 88:453–56. doi:10.15386/cjmed-568.
   PubMedGoogle Scholar
• Saud, S. M., W. Li, N. L. Morris, M. S. Matter, N. H. Colburn, Y. S. Kim, and M. R. Young. 2014. Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis 35:2778–86. doi:10.1093/carcin/bgu209.
   PubMed Web of Science ®Google Scholar
• Scalbert, A., and G. Williamson. 2000. Dietary intake and bioavailability of polyphenols. The Journal of Nutrition 130:2073S–85S. doi:10.1093/jn/130.8.2073S.
   PubMed Web of Science ®Google Scholar
• Sesink, A. L. A., K. A. O'Leary, and P. C. H. Hollman. 2001. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-Glucoside or Quercetin-4′-Glucoside. The Journal of Nutrition 131:1938–41. doi:10.1093/jn/131.7.1938.
   PubMed Web of Science ®Google Scholar
• Sha, M., J. Ye, L.-X. Zhang, Z.-Y. Luan, and Y.-B. Chen. 2013. Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity. Cancer Cell International 13:50. doi:10.1186/1475-2867-13-50.
   PubMed Web of Science ®Google Scholar
• Shah, M. S., L. A. Davidson, and R. S. Chapkin. 2012. Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. Frontiers in Genetics 3:305. doi:10.3389/fgene.2012.00305.
   PubMedGoogle Scholar
• Shah, M. S., S. L. Schwartz, C. Zhao, L. A. Davidson, B. Zhou, J. R. Lupton, I. Ivanov, and R. S. Chapkin. 2011. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiological Genomics 43:640–54. doi:10.1152/physiolgenomics.00213.2010.
   PubMed Web of Science ®Google Scholar
• Shan, B.-E., M.-X. Wang, and R.-Q. Li. 2009. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of Cyclin D1 and survivin expression through Wnt/β-Catenin signaling pathway. Cancer Investigation 27:604–12. doi:10.1080/07357900802337191.
   PubMed Web of Science ®Google Scholar
• Shi, Y., and G. Williamson. 2015. Comparison of the urinary excretion of quercetin glycosides from red onion and aglycone from dietary supplements in healthy subjects: a randomized, single-blinded, cross-over study. Food & Function 6:1443–48. doi:10.1039/C5FO00155B.
   PubMed Web of Science ®Google Scholar
• Shimoi, K., N. Saka, R. Nozawa, M. Sato, I. Amano, T. Nakayama, and N. Kinae. 2001. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metabolism and Disposition 29:1521.
   PubMed Web of Science ®Google Scholar
• Shirode, A. B., P. Kovvuru, S. V. Chittur, S. M. Henning, D. Heber, and R. Reliene. 2014. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Molecular Carcinogenesis 53:458–70. doi:10.1002/mc.21995.
   PubMed Web of Science ®Google Scholar
• Simmering, R., H. Pforte, G. Jacobasch, and M. Blaut. 2002. The growth of the flavonoid-degrading intestinal bacterium, Eubacterium ramulus, is stimulated by dietary flavonoids in vivo. FEMS Microbiology Ecology 40:243–48. doi:10.1111/j.1574-6941.2002.tb00957.x.
   PubMed Web of Science ®Google Scholar
• Sonoki, H., T. Sato, S. Endo, T. Matsunaga, M. Yamaguchi, Y. Yamazaki, J. Sugatani, and A. Ikari. 2015. Quercetin decreases claudin-2 expression mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells. Nutrients 7:4578–92. doi:10.3390/nu7064578.
   PubMed Web of Science ®Google Scholar
• Su, D., R. Zhang, F. Hou, J. Chi, F. Huang, S. Yan, L. Liu, Y. Deng, Z. Wei, and M. Zhang. 2017. Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet. Food & function 8:808–15. doi:10.1039/C6FO01507G.
   PubMed Web of Science ®Google Scholar
• Subramaniam, D., S. Ponnurangam, P. Ramamoorthy, D. Standing, R. J. Battafarano, S. Anant, and P. Sharma. 2012. Curcumin induces cell death in esophageal cancer cells through modulating notch signaling. PLOS ONE 7:e30590. doi:10.1371/journal.pone.0030590.
   PubMed Web of Science ®Google Scholar
• Sun, Q., R. Cong, H. Yan, H. Gu, Y. Zeng, N. Liu, J. Chen, and B. Wang. 2009. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncology Report 22:563–67.
   PubMed Web of Science ®Google Scholar
• Tao, S. F., H. F. He, and Q. Chen. 2015. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells. Mol Cell Biochem 402:93–100. doi:10.1007/s11010-014-2317-7.
   PubMed Web of Science ®Google Scholar
• Terao, J. 2017. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochemestry Pharmacolology 139:15–23. doi:10.1016/j.bcp.2017.03.021.
   PubMed Web of Science ®Google Scholar
• Tili, E., and J.-J. Michaille. 2011. Resveratrol, MicroRNAs, inflammation, and cancer. Journal of Nucleic Acids 2011:102431. doi:10.4061/2011/102431.
   PubMedGoogle Scholar
• Tili, E., J.-J. Michaille, H. Alder, S. Volinia, D. Delmas, N. Latruffe, and C. M. Croce. 2010. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochemical Pharmacology 80:2057–65. doi:10.1016/j.bcp.2010.07.003.
   PubMed Web of Science ®Google Scholar
• Toden, S., Y. Okugawa, C. Buhrmann, D. Nattamai, E. Anguiano, N. Baldwin, M. Shakibaei, C. R. Boland, and A. Goel. 2015. Novel evidence for curcumin and boswellic acid–induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer. Cancer Prevention Research 8:431. doi:10.1158/1940-6207.CAPR-14-0354.
   PubMed Web of Science ®Google Scholar
• Tripoli, E., M. L. Guardia, S. Giammanco, D. D. Majo, and M. Giammanco. 2007. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chemistry 104:466–79. doi:10.1016/j.foodchem.2006.11.054.
   Web of Science ®Google Scholar
• Tsang, W. P., and T. T. Kwok. 2010. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. The Journal of Nutritional Biochemistry 21:140–46. doi:10.1016/j.jnutbio.2008.12.003.
   PubMed Web of Science ®Google Scholar
• Tsoukas, M. A., B.-J. Ko, T. R. Witte, F. Dincer, W. E. Hardman, and C. S. Mantzoros. 2015. Dietary walnut suppression of colorectal cancer in mice: Mediation by miRNA patterns and fatty acid incorporation. The Journal of Nutritional Biochemistry 26:776–83. doi:10.1016/j.jnutbio.2015.02.009.
   PubMed Web of Science ®Google Scholar
• van Harten-Gerritsen, A. S., M. G. J. Balvers, R. F. Witkamp, E. Kampman, and F. J. B. van Duijnhoven. 2015. Vitamin D, inflammation, and colorectal cancer progression: A review of mechanistic studies and future directions for epidemiological studies. Cancer Epidemiology Biomarkers & Prevention 24:1820. doi:10.1158/1055-9965.EPI-15-0601.
   PubMed Web of Science ®Google Scholar
• Volinia, S., G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Harris, and C. M. Croce. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257–61. doi:10.1073/pnas.0510565103.
   PubMed Web of Science ®Google Scholar
• Walle, T. 2004. Absorption and metabolism of flavonoids. Free Radical Biology and Medicine 36:829–37. doi:10.1016/j.freeradbiomed.2004.01.002.
   PubMed Web of Science ®Google Scholar
• Wang, H., S. Bian, and C. S. Yang. 2011. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α. Carcinogenesis 32:1881–89. doi:10.1093/carcin/bgr218.
   PubMed Web of Science ®Google Scholar
• Wang, P., T. Phan, D. Gordon, S. Chung, S. M. Henning, and J. V. Vadgama. 2015. Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Molecular Nutrition & Food Research 59:250–61. doi:10.1002/mnfr.201400558.
   PubMed Web of Science ®Google Scholar
• Watanabe, A., H. Tagawa, J. Yamashita, K. Teshima, M. Nara, K. Iwamoto, M. Kume, Y. Kameoka, N. Takahashi, T. Nakagawa, N. Shimizu, and K. Sawada. 2011. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25:1324–34. doi:10.1038/leu.2011.81.
   PubMed Web of Science ®Google Scholar
• Watanapokasin, R., F. Jarinthanan, Y. Nakamura, N. Sawasjirakij, A. Jaratrungtawee, and S. Suksamrarn. 2011. Effects of α-mangostin on apoptosis induction of human colon cancer. World Journal of Gastroenterology: WJG 17:2086–95. doi:10.3748/wjg.v17.i16.2086.
   PubMed Web of Science ®Google Scholar
• Wein, S., M. Kluth, and S. Wolffram. 2014. Impact of quercetin on hepatic miRNA expression in rats. PharmaNutrition 2:113–14. doi:10.1016/j.phanu.2013.11.110.
   Google Scholar
• Wein, S. A., A. Laviano, and S. Wolffram. 2015. Quercetin induces hepatic gamma-glutamyl hydrolase expression in rats by suppressing hepatic microRNA rno-miR-125b-3p. Journal of Nutrition and Biochemestry 26:1660–63. doi:10.1016/j.jnutbio.2015.08.010.
   PubMed Web of Science ®Google Scholar
• Wen, X.-Y., S.-Y. Wu, Z.-Q. Li, Z-q. Liu, J.-J. Zhang, G.-F. Wang, Z.-H. Jiang, and S.-G. Wu. 2009. Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of MiRNAs in HepG2 cancer cells. Phytotherapy Research 23:778–84. doi:10.1002/ptr.2616.
   PubMed Web of Science ®Google Scholar
• Xu, B., N. Wang, X. Wang, N. Tong, N. Shao, J. Tao, P. Li, X. Niu, N. Feng, L. Zhang, L. Hua, Z. Wang, and M. Chen. 2012. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer. The Prostate 72:1171–78. doi:10.1002/pros.22466.
   PubMed Web of Science ®Google Scholar
• Xu, J., C. X. Li, Y. S. Li, J. Y. Lv, Y. Ma, T. T. Shao, L. D. Xu, Y. Y. Wang, L. Du, Y. P. Zhang, W. Jiang, C. Q. Li, Y. Xiao, and X. Li. 2011. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic Acids Research 39:825–36. doi:10.1093/nar/gkq832.
   PubMed Web of Science ®Google Scholar
• Yang, F. Q., M. Liu, W. Li, J. P. Che, G. C. Wang, and J. H. Zheng. 2015. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA21. Molecular Medicine Reports 11:1085–92. doi:10.3892/mmr.2014.2813.
   PubMed Web of Science ®Google Scholar
• Yang, J., Y. Cao, J. Sun, and Y. Zhang. 2010. Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Medical Oncology 27:1114–18. doi:10.1007/s12032-009-9344-3.
   PubMed Web of Science ®Google Scholar
• Zaman, M. S., S. Thamminana, V. Shahryari, T. Chiyomaru, G. Deng, S. Saini, S. Majid, S. Fukuhara, I. Chang, S. Arora, H. Hirata, K. Ueno, K. Singh, Y. Tanaka, and R. Dahiya. 2012. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLOS ONE 7:e50203. doi:10.1371/journal.pone.0050203.
   PubMed Web of Science ®Google Scholar
• Zhang, C., H. Yu, Y. Shen, X. Ni, S. Shen, and U. N. Das. 2015. Polyunsaturated fatty acids trigger apoptosis of colon cancer cells through a mitochondrial pathway. Archives of Medical Science: AMS 11:1081–94.
   PubMed Web of Science ®Google Scholar
• Zhang, L., S. He, F. Yang, H. Yu, W. Xie, Q. Dai, D. Zhang, X. Liu, S. Zhou, and K. Zhang. 2016. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21. Canadian Journal of Physiology and Pharmacology 94:1249–56. doi:10.1139/cjpp-2016-0066.
   PubMed Web of Science ®Google Scholar
• Zhao, C., and A. S. Popel. 2015. Computational model of MicroRNA control of HIF-VEGF Pathway: Insights into the pathophysiology of ischemic vascular disease and cancer. PLoS Computation Biology 11:e1004612. doi:10.1371/journal.pcbi.1004612.
   PubMed Web of Science ®Google Scholar
• Zhao, J-l., Zhao, J., and H.-J. Jiao. 2014. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. Applied Biochemistry and Biotechnology 172:784–91. doi:10.1007/s12010-013-0561-z.
   PubMed Web of Science ®Google Scholar
• Zhou, D.-H., X. Wang, and Q. Feng. 2014. EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 Cells. Nutr Cancer 66:636–44. doi:10.1080/01635581.2014.894101.
   PubMed Web of Science ®Google Scholar
• Zhu, H., U. Dougherty, V. Robinson, R. Mustafi, J. Pekow, S. Kupfer, Y.-C. Li, J. Hart, K. Goss, A. Fichera, L. Joseph, and M. Bissonnette. 2011. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western Diet–promoted murine colon cancer: Role of G1 Regulators. Molecular Cancer Research 9:960. doi:10.1158/1541-7786.MCR-10-0531.
   PubMed Web of Science ®Google Scholar
• Zhu, W., Y. Zhao, Y. Xu, Y. Sun, Z. Wang, W. Yuan, and Z. Du. 2013. Dissection of protein interactomics highlights MicroRNA synergy. PLOS ONE 8:e63342. doi:10.1371/journal.pone.0063342.
   PubMed Web of Science ®Google Scholar